The Use Of Iproveratril (Isoptin) In Patient With Angina Pectoris

Year 1968, Volume: 21 Issue: 1, 155 - 170, 28.02.1968

Turhan Akyol

https://izlik.org/JA69BE77EN

Abstract

36 patients with intractable angina pectoris were given 240 mg of Verapamil for periods of 760 days. In 2/3 of these patients we obtained good-very good results. Criteria used to evaluate the effect of the medicine were decrease in the numbers of attacts and daily Trinitrine used and increase of effort tolerance.
In another group of 36 patients with angina pectoris the effect of Verapamil Tetraerythrol pentanitrate and placebo were compared. In this group maximal effort capacity was determined by a bycicle type of ergometer for each patient before and after treatment. Results obtained with Verapamil are francly superior to those of nitrites and placebo.

Keywords

Verapamil , Angina pectoris , Nitrites

Verapamil (İsoptin) İle Angina Pektorisli Hastalarda Aldığımız Neticeler

https://izlik.org/JA69BE77EN

Abstract

Mutad tedaviye cevap vermeyen 36 angina pektoris vakasında Verapamil (Isoptin) kullanıldı. İlacın tesirini değerlendirmekte nöbet sayısı, günlük Trinitrin adedindeki azalma ve efor toleransı kriter olarak kullanıldı. Vakaların 2/3 ünde iyi çok iyi netice alındı.
36 kişilik diğer bir gurun angina pektorisli hastada Verapamil, Pentaerythrol tetranitrat, ve placebo'nun tesirleri mukayeseli olarak incelendi. Tesir kriteri olarak daha objektif şekilde ergometrede tedaviden önce ve sonra maksimal efor kapasitesi tayin edildi. Verapamil'in Nitritler ve placebo'ya nazaran aşikâr üstünlük gösterdiği tesbit edildi.

Keywords

Verapamil , Angina pektoris , Nitrit

References

• 1. PERLOFF J. K. ve GURUBU: Systemic hemodynamic effects of amyl nitrite in normal man. Am. Heart Jl. 66: 460, 1963.
• 2. LUEBS E. D. ve GURUBU: Effect of nitroglycerin, Intensain, Isoptin and papaverine on coronary blood flow in man measured by the coincldence counting technic and Ripidium. Am. Jl Cardiology 17: 535, 1966.
• 3. RAYMOND P. A.: A Study of the adrenotropic receptors. Am. Jl. Physiology 586, 1948.
• 4. KAYMAKÇALAN Ş.: Tıbbi Farmakoloji Ankara Üniversitesi Tıp Fakültesi yayınları 1966.
• 5. H. HAAS ve G. HAERTFELDER: α-Isopropyl- α N-methyl-N-homoveratryl-γ- aminopropyl- 3,4- dimethoxyphenyl-acetonitril, eine Substanz mit coronargefaesserweiternden Eigenschaften. Arzneimittel-Forschung (Drug Research) 12: 549, 1962.
• 6. M. SCHLEPPER ve E. WITZLEB: Tierexperimentelle Untersuchungen über die Veraenderungen von Coronardurchbultung. Arzneimittel-Forschung 12: 559, 1962.
• 7. J. C. DIDISHEIM ve R. UEBERSAX: Essal clinique d'un nouvenau médicament vaso-dilatateur coranarien, le D. 365. Medicine et Hygiene 22: 863-865, 1964.
• 8. B. STRAESSLE ve D. BURCKHARDT: Isoptin (d-365) Klinische Untersuchungen zur Behandlung coronarer Herzkrankhelt. Schweizerische Medizinische Woshenschrift 95: 667-672, 1965.
• 9. G. KNOCH. M. SCHLEPPER ve E. WITZLEB: Untersuchungen an gesunden und Koronarkranken Patienten mit Isoptin. Medizinische Klinik 58: 1485, 1963.
• 10. F. W. SCHMAHL ve E. BETZ: Die Wirkung von α-Isopropyl α[(N- methyl-N-homoveratryl)- γ- amino propyl]- 3,4 dimethoxyphenylacetonitril auf die Durchblutung von Myocard, Leber-Niere, Skletturus culatur und Gehirn der Katze Arzneimittel-Forschung 14: 1159, 1966.